Dealmaking

Clearlake buys Pathway Capital as private markets firms consolidate; Godspeed invests in space infrastructure provider JP Donovan

Speaking with Ryan Craig, co-founder and managing director of Achieve Partners, to discuss the firm's investment in Alchemy, which helps companies build and manage internship programs; talking with Douglas T. Lake, Jr., founder and managing partner at Godspeed Capital, to discuss opportunities driving investments in the space infrastructure sector.

Permira’s Silvia Oteri: integration, scale, clinical trust key for healthcare businesses in AI era; Thoma Bravo agrees to acquire life science software company Kneat

CapMan Growth has agreed to sell its stake in Silmäasema, a Finnish eye health and optical retail operator.

Thoma Bravo eyes cross-sell opportunities with HCSS and Nemetschek combo; Brand Velocity’s acquisition of RCX Sports highlights PE’s interest in youth sports

With Thoma Bravo agreeing in April to combine HCSS with Nemetschek’s build and construct segment, we’ll look at how the combined entity can help HCSS going forward; also: exploring private equity’s interest in youth sports.

PE enters a tougher era as volatility clouds recovery – Bain

Activity slowed in the first quarter as AI disruption, private credit pressures and geopolitical uncertainty weighed on the market, according to Bain & Company’s latest PE report.

Thoma Bravo sees AI and cross-sell opportunity for HCSS with Nemetschek combination

'This combination sets us up to be the vertical AI and SaaS leader across the entire AEC ecosystem,' says Thoma Bravo's AJ Rohde.

Dual track processes, IPO readiness in vogue, says Alvarez & Marsal; Sharp reduction in dealmaking, finds Bain & Co midyear report

'Clients want to run processes where they’ll see what bids come in and also see how the public markets will value the exit,' says Alvarez & Marsal's Paul Aversano.

Warburg, Martis, MKH Capital eye substance use care assets; Outpatient radiology demand drives Kain Capital’s investment in RadX

Exploring trends attracting firms such as Warburg Pincus, Martis Capital and MKH Capital to the substance use disorder sector; a look into a recent investment by Kain Capital in the outpatient radiology sector.

PE targets substance use care: 5 deals

Warburg Pincus, Frazier Healthcare Partners, Lee Equity and Sheridan are among the PE firms investing in the substance use care assets.

Fraud more common in M&A than ever before, says Aon; Apollo withdraws $2bn bid for Bodycote

Bodycote is a London-listed heat treatment and metallurgical services provider.

AI's impact on deal sourcing, value creation, exits and returns explored at PEI Group’s Women in Private Markets Summit; Wynnchurch exits Labrie to Finnish strategic for $1.4bn

AI was everything everywhere all at once this week at PEI Group’s fourth annual Women in Private Markets Summit: North America; weekly update on companies for sale, featuring Wynnchurch’s exit of a garbage truck company.